Circulation Research. 2004;95:692-699
Published online before print September 2, 2004, doi: 10.1161/01.RES.0000144126.57786.89
Published online before print September 2, 2004, doi: 10.1161/01.RES.0000144126.57786.89
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2004 American Heart Association, Inc.
Molecular Medicine |
17ß-Estradiol Reduces Cardiomyocyte Apoptosis In Vivo and In Vitro via Activation of Phospho-Inositide-3 Kinase/Akt Signaling
From the Molecular Cardiology Research Institute (R.D.P., I.P., M.J.A., J.B., F.C., X.C., A.M., S.H., T.F., M.E.M., R.H.K.), Tufts-New England Medical Center, Boston, Mass; and Medizinische Universitäts-Poliklinik (S.N., C.G.), Bonn, Germany.
Correspondence to Richard D. Patten, MD, Investigator, Molecular Cardiology Research Institute, Assistant Professor of Medicine Department of Medicine, Tufts-New England Medical Center, 750 Washington St, Boston MA 02111. E-mail rpatten{at}tufts-nemc.org
Female gender and estrogen-replacement therapy in postmenopausal women are associated with improved heart failure survival, and physiological replacement of 17ß-estradiol (E2) reduces infarct size and cardiomyocyte apoptosis in animal models of myocardial infarction (MI). Here, we characterize the molecular mechanisms of E2 effects on cardiomyocyte survival in vivo and in vitro. Ovariectomized female mice were treated with placebo or physiological E2 replacement, followed by coronary artery ligation (placebo-MI or E2-MI) or sham operation (sham) and hearts were harvested 6, 24, and 72 hours later. After MI, E2 replacement significantly increased activation of the prosurvival kinase, Akt, and decreased cardiomyocyte apoptosis assessed by terminal deoxynucleotidyltransferase dUTP nick-end labeling (TUNEL) staining and caspase 3 activation. In vitro, E2 at 1 or 10 nmol/L caused a rapid 2.7-fold increase in Akt phosphorylation and a decrease in apoptosis as measured by TUNEL staining, caspase 3 activation, and DNA laddering in cultured neonatal rat cardiomyocytes. The E2-mediated reduction in apoptosis was reversed by an estrogen receptor (ER) antagonist, ICI 182,780, and by phospho-inositide-3 kinase inhibitors, LY294002 and Wortmannin. Overexpression of a dominant negative-Akt construct also blocked E2-mediated reduction in cardiomyocyte apoptosis. These data show that E2 reduces cardiomyocyte apoptosis in vivo and in vitro by ER- and phospho-inositide-3 kinase–Akt–dependent pathways and support the relevance of these pathways in the observed estrogen-mediated reduction in myocardial injury.
Key Words: estrogen • estrogen receptors • myocardial infarction • cardiomyocyte • apoptosis • Akt • PI3 kinase
This article has been cited by other articles:
 |
|
 |
|
  R. Rouf, S. Greytak, E. C. Wooten, J. Wu, J. Boltax, M. Picard, E. C. Svensson, W. H. Dillmann, R. D. Patten, and G. S. Huggins Increased FOG-2 in Failing Myocardium Disrupts Thyroid Hormone-Dependent SERCA2 Gene Transcription Circ. Res., August 29, 2008; 103(5): 493 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Lemon, C. D. Rollo, N. M. McFarlane, and D. R. Boreham Radiation-induced apoptosis in mouse lymphocytes is modified by a complex dietary supplement: the effect of genotype and gender Mutagenesis, July 21, 2008; (2008) gen038v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Raju and I. H. Chaudry Sex Steroids/Receptor Antagonist: Their Use as Adjuncts After Trauma-Hemorrhage for Improving Immune/Cardiovascular Responses and for Decreasing Mortality from Subsequent Sepsis Anesth. Analg., July 1, 2008; 107(1): 159 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Hutchens, J. Dunlap, P. D. Hurn, and P. O. Jarnberg Renal Ischemia: Does Sex Matter? Anesth. Analg., July 1, 2008; 107(1): 239 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Merkel, L. Liu, Z. Cao, W. Packwood, P. D. Hurn, and D. M. Van Winkle Estradiol abolishes reduction in cell death by the opioid agonist Met5-enkephalin after oxygen glucose deprivation in isolated cardiomyocytes from both sexes Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H409 - H415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L Jeanes, C. Tabor, D. Black, A. Ederveen, and G. A Gray Oestrogen-mediated cardioprotection following ischaemia and reperfusion is mimicked by an oestrogen receptor (ER){alpha} agonist and unaffected by an ER{beta} antagonist J. Endocrinol., June 1, 2008; 197(3): 493 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vasconsuelo, L. Milanesi, and R. Boland 17{beta}-Estradiol abrogates apoptosis in murine skeletal muscle cells through estrogen receptors: role of the phosphatidylinositol 3-kinase/Akt pathway J. Endocrinol., February 1, 2008; 196(2): 385 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Enns and P. M. Tiidus Estrogen influences satellite cell activation and proliferation following downhill running in rats J Appl Physiol, February 1, 2008; 104(2): 347 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Gardner, G. L. Brower, T. G. Voloshenyuk, and J. S. Janicki Cardioprotection in female rats subjected to chronic volume overload: synergistic interaction of estrogen and phytoestrogens Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H198 - H204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Cao, L. Liu, W. Packwood, M. Merkel, P. D. Hurn, and D. M. Van Winkle Sex differences in the mechanism of Met5-enkephalin-induced cardioprotection: role of PI3K/Akt Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H302 - H310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Konhilas and L. A. Leinwand The Effects of Biological Sex and Diet on the Development of Heart Failure Circulation, December 4, 2007; 116(23): 2747 - 2759. [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Hammes and E. R. Levin Extranuclear Steroid Receptors: Nature and Actions Endocr. Rev., December 1, 2007; 28(7): 726 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Hirsch, C. Costa, and E. Ciraolo Phosphoinositide 3-kinases as a common platform for multi-hormone signaling J. Endocrinol., August 1, 2007; 194(2): 243 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Straub The Complex Role of Estrogens in Inflammation Endocr. Rev., August 1, 2007; 28(5): 521 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Satoh, C. M. Matter, H. Ogita, K. Takeshita, C.-Y. Wang, G. W. Dorn II, and J. K. Liao Inhibition of Apoptosis-Regulated Signaling Kinase-1 and Prevention of Congestive Heart Failure by Estrogen Circulation, June 26, 2007; 115(25): 3197 - 3204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Wierman and W. M. Kohrt Review Article: Vascular and Metabolic Effects of Sex Steroids: New Insights Into Clinical Trials Reproductive Sciences, May 1, 2007; 14(4): 300 - 314. [Abstract] [PDF]
|
|
|
|
 |
|
 C. F. Deschepper and B. Llamas Hypertensive Cardiac Remodeling in Males and Females: From the Bench to the Bedside Hypertension, March 1, 2007; 49(3): 401 - 407. [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Hunter, J. C. Kostyak, J. L. Novotny, A. M. Simpson, and D. H. Korzick Estrogen deficiency decreases ischemic tolerance in the aged rat heart: roles of PKC{delta}, PKC{epsilon}, Akt, and GSK3beta Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R800 - R809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bupha-Intr, J. Wattanapermpool, J. R. Pena, B. M. Wolska, and R. J. Solaro Myofilament response to Ca2+ and Na+/H+ exchanger activity in sex hormone-related protection of cardiac myocytes from deactivation in hypercapnic acidosis Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R837 - R843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. X-D Song, P. Fan, W. Yue, Y. Chen, and R. J Santen Role of receptor complexes in the extranuclear actions of estrogen receptor {alpha} in breast cancer Endocr. Relat. Cancer, December 1, 2006; 13(Supplement_1): S3 - S13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Dawn and R. Bolli Increasing Evidence That Estrogen Is an Important Modulator of Bone Marrow-Mediated Cardiac Repair After Acute Infarction Circulation, November 21, 2006; 114(21): 2203 - 2205. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Dalal, C. James, R. Devanagondi, C. Tichnell, A. Tucker, K. Prakasa, P. J. Spevak, D. A. Bluemke, T. Abraham, S. D. Russell, et al. Penetrance of Mutations in Plakophilin-2 Among Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1416 - 1424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tsujita, J. Muraski, I. Shiraishi, T. Kato, J. Kajstura, P. Anversa, and M. A. Sussman Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy PNAS, August 8, 2006; 103(32): 11946 - 11951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Xu, R. D. Patten, T. Force, and J. M. Kyriakis Gene 33/RALT Is Induced by Hypoxia in Cardiomyocytes, Where It Promotes Cell Death by Suppressing Phosphatidylinositol 3-Kinase and Extracellular Signal-Regulated Kinase Survival Signaling. Mol. Cell. Biol., July 1, 2006; 26(13): 5043 - 5054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. X.-D. Song and R. J. Santen Membrane Initiated Estrogen Signaling in Breast Cancer Biol Reprod, July 1, 2006; 75(1): 9 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-C. Hsieh, M. A. Choudhry, H.-P. Yu, T. Shimizu, S. Yang, T. Suzuki, J. Chen, K. I. Bland, and I. H. Chaudry Inhibition of cardiac PGC-1{alpha} expression abolishes ER{beta} agonist-mediated cardioprotection following trauma-hemorrhage FASEB J, June 1, 2006; 20(8): 1109 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wang, P. Crisostomo, G. M. Wairiuko, and D. R. Meldrum Estrogen receptor-{alpha} mediates acute myocardial protection in females Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2204 - H2209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mahmoodzadeh, S. Eder, J. Nordmeyer, E. Ehler, O. Huber, P. Martus, J. Weiske, R. Pregla, R. Hetzer, and V. Regitz-Zagrosek Estrogen receptor alpha up-regulation and redistribution in human heart failure FASEB J, May 1, 2006; 20(7): 926 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Kim, A. Pedram, M. Razandi, and E. R. Levin Estrogen Prevents Cardiomyocyte Apoptosis through Inhibition of Reactive Oxygen Species and Differential Regulation of p38 Kinase Isoforms J. Biol. Chem., March 10, 2006; 281(10): 6760 - 6767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kempf, M. Eden, J. Strelau, M. Naguib, C. Willenbockel, J. Tongers, J. Heineke, D. Kotlarz, J. Xu, J. D. Molkentin, et al. The Transforming Growth Factor-{beta} Superfamily Member Growth-Differentiation Factor-15 Protects the Heart From Ischemia/Reperfusion Injury Circ. Res., February 17, 2006; 98(3): 351 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sitnick, A. M. Foley, M. Brown, and E. E. Spangenburg Ovariectomy prevents the recovery of atrophied gastrocnemius skeletal muscle mass J Appl Physiol, January 1, 2006; 100(1): 286 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kher, K. K. Meldrum, M. Wang, B. M. Tsai, J. M. Pitcher, and D. R. Meldrum Cellular and molecular mechanisms of sex differences in renal ischemia-reperfusion injury Cardiovasc Res, September 1, 2005; 67(4): 594 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Stassi, M. Garofalo, M. Zerilli, L. Ricci-Vitiani, C. Zanca, M. Todaro, F. Aragona, G. Limite, G. Petrella, and G. Condorelli PED Mediates AKT-Dependent Chemoresistance in Human Breast Cancer Cells Cancer Res., August 1, 2005; 65(15): 6668 - 6675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Mendelsohn and R. H. Karas Molecular and Cellular Basis of Cardiovascular Gender Differences Science, June 10, 2005; 308(5728): 1583 - 1587. [Abstract] [Full Text] [PDF]
|
|